Product correctly added to cart.

discount label
Captopril EP Impurity F
View 3D

Biosynth logo

Captopril EP Impurity F

CAS: 63250-36-2

Ref. 3D-FC179763

1mgTo inquire
2mgTo inquire
5mgTo inquire
10mgTo inquire
25mgTo inquire
Estimated delivery in United States, on Wednesday 26 Jun 2024

Product Information

Name:
Captopril EP Impurity F
Description:

Captopril EP Impurity F is a potent inhibitor of angiotensin-converting enzyme (ACE) and also possesses some natriuretic peptide activity. Captopril EP Impurity F has been shown to be a potent bronchoconstrictor in two-way crossover studies with colloidal gold signal peptide. Captopril EP Impurity F binds to the active site of ACE and prevents the conversion of angiotensin I to angiotensin II, which is an important mediator of vasoconstriction and blood pressure regulation. Captopril EP Impurity F also inhibits the production of prostaglandin E2, which may contribute to its anti-inflammatory effects. Captopril EP Impurity F has been shown to have cardioprotective effects in animal models of myocardial infarction and pulmonary hypertension, probably due to its ability to inhibit the production of proinflammatory mediators such as nitric oxide.

Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
217.29 g/mol
Formula:
C9H15NO3S
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-FC179763 Captopril EP Impurity F

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".